<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38130596</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2328-8957</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Open forum infectious diseases</Title><ISOAbbreviation>Open Forum Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort Study.</ArticleTitle><Pagination><StartPage>ofad579</StartPage><MedlinePgn>ofad579</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ofad579</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ofid/ofad579</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The long-term effects of coronavirus disease 2019 (COVID-19) on physical fitness are unclear, and the impact of vaccination on that relationship is uncertain.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We compared survey responses in a 1-year study of US military service members with (n = 1923) and without (n = 1591) a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We fit Poisson regression models to estimate the association between history of SARS-CoV-2 infection and fitness impairment, adjusting for time since infection, demographics, and baseline health.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The participants in this analysis were primarily young adults aged 18-39 years (75%), and 71.5% were male. Participants with a history of SARS-CoV-2 infection were more likely to report difficulty exercising (38.7% vs 18.4%; <i>P</i> &lt; .01), difficulty performing daily activities (30.4% vs 12.7%; <i>P</i> &lt; .01), and decreased fitness test (FT) scores (42.7% vs 26.2%; <i>P</i> &lt; .01) than those without a history of infection. SARS-CoV-2-infected participants were at higher risk of these outcomes after adjusting for other factors (unvaccinated: exercising: adjusted risk ratio [aRR], 3.99; 95% CI, 3.36-4.73; activities: aRR, 5.02; 95% CI, 4.09-6.16; FT affected: aRR, 2.55; 95% CI, 2.19-2.98). Among SARS-CoV-2-positive participants, full vaccination before infection was associated with a lower risk of post-COVID-19 fitness impairment (fully vaccinated: exercise: aRR, 0.81; 95% CI, 0.70-0.95; activities: aRR, 0.76; 95% CI, 0.64-0.91; FT: aRR, 0.87; 95% CI, 0.76-1.00; boosted: exercise: aRR, 0.62; 95% CI, 0.51-0.74; activities: aRR, 0.52; 95% CI, 0.41-0.65; FT: aRR, 0.59; 95% CI, 0.49-0.70).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">In this study of generally young, healthy military service members, SARS-CoV-2 infection was associated with lower self-reported fitness and exercise capacity; vaccination and boosting were associated with lower risk of self-reported fitness loss.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Richard</LastName><ForeName>Stephanie A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-0530-384X</Identifier><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scher</LastName><ForeName>Ann I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rusiecki</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byrne</LastName><ForeName>Celia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berjohn</LastName><ForeName>Catherine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Naval Medical Center San Diego, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fries</LastName><ForeName>Anthony C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>US Air Force School of Aerospace Medicine, Wright-Patterson, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lalani</LastName><ForeName>Tahaniyat</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-9361-2991</Identifier><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Naval Medical Center Portsmouth, Portsmouth, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Alfred G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Naval Medical Center Portsmouth, Portsmouth, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mody</LastName><ForeName>Rupal M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>William Beaumont Army Medical Center, El Paso, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganesan</LastName><ForeName>Anuradha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Walter Reed National Military Medical Center, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huprikar</LastName><ForeName>Nikhil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Walter Reed National Military Medical Center, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Rhonda E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Madigan Army Medical Center, Joint Base Lewis McChord, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Madigan Army Medical Center, Joint Base Lewis McChord, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schofield</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Madigan Army Medical Center, Joint Base Lewis McChord, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindholm</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brooke Army Medical Center, Joint Base San Antonio-Fort Sam Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mende</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brooke Army Medical Center, Joint Base San Antonio-Fort Sam Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Brooke Army Medical Center, Joint Base San Antonio-Fort Sam Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Milissa U</ForeName><Initials>MU</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Translational Medicine Unit, Uniformed Services University, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flanagan</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Translational Medicine Unit, Uniformed Services University, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larson</LastName><ForeName>Derek T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Naval Medical Center San Diego, San Diego, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alexander T. Augusta Military Medical Center, Fort Belvoir, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ewers</LastName><ForeName>Evan C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alexander T. Augusta Military Medical Center, Fort Belvoir, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazan</LastName><ForeName>Samantha E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Carl R. Darnall Army Medical Center, Fort Cavazos, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saunders</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maves</LastName><ForeName>Ryan C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livezey</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Clinical Pharmacology and Medical Toxicology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maldonado</LastName><ForeName>Carlos J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Womack Army Medical Center, Fort Liberty, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edwards</LastName><ForeName>Margaret Sanchez</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rozman</LastName><ForeName>Julia S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connell</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simons</LastName><ForeName>Mark P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tribble</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agan</LastName><ForeName>Brian K</ForeName><Initials>BK</Initials><Identifier Source="ORCID">0000-0002-5114-1669</Identifier><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgess</LastName><ForeName>Timothy H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pollett</LastName><ForeName>Simon D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>EPICC COVID-19 Cohort Study Group </CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Y01 AI005072</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Open Forum Infect Dis</MedlineTA><NlmUniqueID>101637045</NlmUniqueID><ISSNLinking>2328-8957</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">fitness</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList><CoiStatement>Potential conflicts of interest.&#x2003;1045 S.D.P., T.H.B., J.S.R., and M.P.S. report that the Uniformed Services University (USU) Infectious Diseases Clinical Research Program (IDCRP), a US Department of Defense institution, and the HJF were funded under a Cooperative Research and Development Agreement to conduct an unrelated phase III COVID-19 monoclonal antibody immunoprophylaxis trial sponsored by AstraZeneca. The HJF, in support of the USU IDCRP, was funded by the Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense to augment the conduct of an unrelated phase III vaccine trial sponsored by AstraZeneca. Both trials were part of the US Government COVID-19 response. Neither is related to the work presented here. R.C.M. receives research support paid to his institution from Sound Pharmaceuticals for an investigational COVID-19 therapeutic unrelated to the work presented here. M.J.M. is a paid speaker for Xarelto (Janssen Pharmaceuticals). All other authors report no potential conflicts.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Cowden</LastName><ForeName>Col J</ForeName><Initials>CJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Darling</LastName><ForeName>Ltc M</ForeName><Initials>LM</Initials></Investigator><Investigator ValidYN="Y"><LastName>DeLeon</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lindholm</LastName><ForeName>Maj D</ForeName><Initials>MD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Markelz</LastName><ForeName>Ltc A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mende</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Merritt</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Merritt</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turner</LastName><ForeName>Ltc N</ForeName><Initials>LN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wellington</LastName><ForeName>Cpt T</ForeName><Initials>CT</Initials></Investigator><Investigator ValidYN="Y"><LastName>R</LastName><ForeName>Carl</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bazan</LastName><ForeName>Ltc S</ForeName><Initials>LS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Love</LastName><ForeName>P K</ForeName><Initials>PK</Initials></Investigator><Investigator ValidYN="Y"><LastName>T</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dimascio-Johnson</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elnahas</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ewers</LastName><ForeName>Maj E</ForeName><Initials>ME</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gallagher</LastName><ForeName>Lcdr K</ForeName><Initials>LK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Glinn</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jarral</LastName><ForeName>U</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jennings</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Larson</LastName><ForeName>Lcdr D</ForeName><Initials>LD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reterstoff</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rutt</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silva</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>West</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>M</LastName><ForeName>Henry</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blair</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chenoweth</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clark</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bowman</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chambers</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colombo</LastName><ForeName>Ltc C</ForeName><Initials>LC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colombo</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Conlon</LastName><ForeName>Cpt C</ForeName><Initials>CC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Everson</LastName><ForeName>Cpt K</ForeName><Initials>CK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Faestel</LastName><ForeName>Col P</ForeName><Initials>CP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferguson</LastName><ForeName>Col T</ForeName><Initials>CT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gordon</LastName><ForeName>Maj L</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grogan</LastName><ForeName>Ltc S</ForeName><Initials>LS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lis</LastName><ForeName>Cpt S</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mount</LastName><ForeName>Col C</ForeName><Initials>CC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Musfeldt</LastName><ForeName>Ltc D</ForeName><Initials>LD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Odineal</LastName><ForeName>Cpt D</ForeName><Initials>CD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perreault</LastName><ForeName>Ltc M</ForeName><Initials>LM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robb-McGrath</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sainato</LastName><ForeName>Maj R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schofield</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Skinner</LastName><ForeName>Col C</ForeName><Initials>CC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stein</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Switzer</LastName><ForeName>Maj M</ForeName><Initials>MM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Timlin</LastName><ForeName>Maj M</ForeName><Initials>MM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wood</LastName><ForeName>Maj S</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Banks</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carpenter</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kronmann</LastName><ForeName>Capt K</ForeName><Initials>CK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lalani</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Lcdr T</ForeName><Initials>LT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Lcdr A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tant</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Warkentien</LastName><ForeName>Cdr T</ForeName><Initials>CT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berjohn</LastName><ForeName>Cdr C</ForeName><Initials>CC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cammarata</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kirkland</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Libraty</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maves</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Utz</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bradley</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chi</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flanagan</LastName><ForeName>Ltc R</ForeName><Initials>LR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fuentes</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>Maj M</ForeName><Initials>MM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leslie</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lucas</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Madar</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miyasato</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uyehara</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adams</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agan</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andronescu</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Austin</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Broder</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burgess</LastName><ForeName>Capt T</ForeName><Initials>CT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Byrne</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chung</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davies</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>English</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Epsi</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fox</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fritschlanski</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hadley</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hickey</LastName><ForeName>Col P</ForeName><Initials>CP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laing</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lanteri</LastName><ForeName>Ltc C</ForeName><Initials>LC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Livezey</LastName><ForeName>Ltc J</ForeName><Initials>LJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malloy</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mohammed</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morales</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nwachukwu</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Olsen</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parmelee</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pollett</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richard</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rozman</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rusiecki</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saunders</LastName><ForeName>Col D</ForeName><Initials>CD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Samuels</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanchez</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scher</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simons</LastName><ForeName>Cdr M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Snow</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Telu</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tribble</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tso</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ulomi</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wayman</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hockenbury</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chao</LastName><ForeName>TSgt T</ForeName><Initials>TT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chapleau</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Christian</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fries</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harrington</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hogan</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huntsberger</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lanter</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Macias</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meyer</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Purves</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reynolds</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Starr</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iskander</LastName><ForeName>Capt J</ForeName><Initials>CJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kamara</LastName><ForeName>Cdr I</ForeName><Initials>CI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barton</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hostler</LastName><ForeName>Ltc D</ForeName><Initials>LD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hostler</LastName><ForeName>Ltc J</ForeName><Initials>LJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lago</LastName><ForeName>Maj K</ForeName><Initials>MK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maldonado</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehrer</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hunter</LastName><ForeName>Maj T</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mejia</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mody</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montes</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Resendez</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sandoval</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barahona</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baya</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ganesan</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huprikar</LastName><ForeName>Maj N</ForeName><Initials>MN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peel</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>3</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38130596</ArticleId><ArticleId IdType="pmc">PMC10733205</ArticleId><ArticleId IdType="doi">10.1093/ofid/ofad579</ArticleId><ArticleId IdType="pii">ofad579</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bowe &#xa0;B, Xie &#xa0;Y, Al-Aly &#xa0;Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med &#xa0;2022; 28:2398&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld &#xa0;MS, Sun &#xa0;K, Tahir &#xa0;P, et al. &#xa0;Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults: a systematic review and meta-analysis. JAMA Netw Open &#xa0;2022; 5:e2236057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9557896</ArticleId><ArticleId IdType="pubmed">36223120</ArticleId></ArticleIdList></Reference><Reference><Citation>Rienks &#xa0;R, Holdsworth &#xa0;D, Davos &#xa0;CH, et al. &#xa0;Cardiopulmonary assessment prior to returning to high-hazard occupations post-symptomatic COVID-19 infection: a position statement of the Aviation and Occupational Cardiology Task Force of the European Association of Preventive Cardiology. Eur J Prev Cardiol &#xa0;2022; 29:1724&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8992320</ArticleId><ArticleId IdType="pubmed">35266533</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Sullivan &#xa0;O, Rienks &#xa0;R, et al. &#xa0;Vaccines and variants: an update on cardiopulmonary assessment prior to return to high-hazard occupations following COVID-19. Eur J Prev Cardiol &#xa0;2022; 30:177&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9619731</ArticleId><ArticleId IdType="pubmed">36200288</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention . COVID Data Tracker. Available at: https://covid.cdc.gov/covid-data-tracker/#datatracker-home. Accessed December 4, 2022.</Citation></Reference><Reference><Citation>Perlis &#xa0;RH, Santillana &#xa0;M, Ognyanova &#xa0;K, et al. &#xa0;Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw Open &#xa0;2022; 5:e2238804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani &#xa0;D, Bermingham &#xa0;C. Coronavirus (COVID-19) Vaccination and Self-reported Long COVID in the UK: 25 October 2021. UK Office for National Statistics; 2021.</Citation></Reference><Reference><Citation>Al-Aly &#xa0;Z, Bowe &#xa0;B, Xie &#xa0;Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med &#xa0;2022; 28:1461&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard &#xa0;SA, Pollett &#xa0;SD, Fries &#xa0;AC, et al. &#xa0;Persistent COVID-19 symptoms at six months after onset and the role of vaccination before or after SARS-CoV-2 infection. JAMA Netw Open &#xa0;2023; 6:e2251360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9857077</ArticleId><ArticleId IdType="pubmed">36652247</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet &#xa0;M, Dercon &#xa0;Q, Harrison &#xa0;PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun &#xa0;2022; 103:154&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunvoll &#xa0;SH, Nygaard &#xa0;AB, Fagerland &#xa0;MW, et al. &#xa0;Post-acute symptoms 3&#x2013;15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection. Int J Infect Dis &#xa0;2022; 126:10&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9651990</ArticleId><ArticleId IdType="pubmed">36375693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwaah &#xa0;B, Gruner &#xa0;W, DeMarcus &#xa0;L, et al. &#xa0;Surveillance trends for SARS-CoV-2 and other respiratory pathogens among US military health system beneficiaries, 27 September 2020&#x2013;2 October 2021. MSMR &#xa0;2022; 29:2&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">36250533</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard &#xa0;SA, Pollett &#xa0;SD, Lanteri &#xa0;CA, et al. &#xa0;COVID-19 outcomes among US military health system beneficiaries include complications across multiple organ systems and substantial functional impairment. Open Forum Infect Dis &#xa0;2021; 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8664684</ArticleId><ArticleId IdType="pubmed">34909439</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard &#xa0;SA, Epsi &#xa0;NJ, Lindholm &#xa0;DA, et al. &#xa0;COVID-19 patient-reported symptoms using FLU-PRO plus in a cohort study: associations with infecting genotype, vaccine history, and return to health. Open Forum Infect Dis &#xa0;2022; 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214183</ArticleId><ArticleId IdType="pubmed">35873301</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedegah &#xa0;M, Porter &#xa0;C, Hollingdale &#xa0;MR, et al. &#xa0;CHARM: COVID-19 health action response for marines-association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test. PLoS One &#xa0;2022; 17:e0266691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8989306</ArticleId><ArticleId IdType="pubmed">35390102</ArticleId></ArticleIdList></Reference><Reference><Citation>Letizia &#xa0;AG, Ramos &#xa0;I, Obla &#xa0;A, et al. &#xa0;SARS-CoV-2 transmission among marine recruits during quarantine. N Engl J Med &#xa0;2020; 383:2407&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675690</ArticleId><ArticleId IdType="pubmed">33176093</ArticleId></ArticleIdList></Reference><Reference><Citation>Crameri &#xa0;GAG, Bielecki &#xa0;M, Z&#xfc;st &#xa0;R, Buehrer &#xa0;TW, Stanga &#xa0;Z, Deuel &#xa0;JW. Reduced maximal aerobic capacity after COVID-19 in young adult recruits, Switzerland, May 2020. Euro Surveill &#xa0;2020; 25:2001542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7502899</ArticleId><ArticleId IdType="pubmed">32914744</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Sullivan &#xa0;O, Holdsworth &#xa0;DA, et al. &#xa0;Cardiopulmonary, functional, cognitive and mental health outcomes post-COVID-19, across the range of severity of acute illness, in a physically active, working-age population. Sports Med Open &#xa0;2023; 9:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9893959</ArticleId><ArticleId IdType="pubmed">36729302</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler &#xa0;EL, Stahlman &#xa0;SL, Wells &#xa0;NY, et al. &#xa0;COVID-19 booster vaccination in the US military, August 2021&#x2013;January 2022. Am J Prev Med &#xa0;2022; 64:270&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9420709</ArticleId><ArticleId IdType="pubmed">36123230</ArticleId></ArticleIdList></Reference><Reference><Citation>Fast &#xa0;HE, Murthy &#xa0;BP, Zell &#xa0;E, et al. &#xa0;Booster COVID-19 vaccinations among persons aged &gt;/=5 years and second booster COVID-19 vaccinations among persons aged &gt;/=50 years&#x2014;United States, August 13, 2021&#x2013;August 5, 2022. MMWR Morb Mortal Wkly Rep &#xa0;2022; 71:1121&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9472775</ArticleId><ArticleId IdType="pubmed">36048732</ArticleId></ArticleIdList></Reference><Reference><Citation>Epsi &#xa0;NJ, Richard &#xa0;SA, Laing &#xa0;ED, et al. &#xa0;Clinical, immunological and virological SARS-CoV-2 phenotypes in obese and non-obese military health system beneficiaries. J Infect Dis &#xa0;2021; 224:1462&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8385847</ArticleId><ArticleId IdType="pubmed">34331541</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson &#xa0;ME, Pompei &#xa0;P, Ales &#xa0;KL, MacKenzie &#xa0;CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis &#xa0;1987; 40:373&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>
CoVariants: SARS-CoV-2 mutations and variants of interest . Available at: https://covariants.org/. Accessed October 28, 2022.</Citation></Reference><Reference><Citation>Deuel &#xa0;JW, Lauria &#xa0;E, Lovey &#xa0;T, et al. &#xa0;Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the Swiss armed forces: a longitudinal, cohort study (LoCoMo). Lancet Infect Dis &#xa0;2022; 22:1694&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9411260</ArticleId><ArticleId IdType="pubmed">36030795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladlow &#xa0;P, Holdsworth &#xa0;DA, O'Sullivan &#xa0;O, et al. &#xa0;Exercise tolerance, fatigue, mental health, and employment status at 5 and 12 months following COVID-19 illness in a physically trained population. J Appl Physiol &#xa0;2023; 134:622&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10010915</ArticleId><ArticleId IdType="pubmed">36759161</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanga &#xa0;V, Chevinsky &#xa0;JR, Dimitrov &#xa0;LV, et al. &#xa0;Long-term symptoms among adults tested for SARS-CoV-2&#x2014;United States, January 2020&#x2013;April 2021. MMWR Morb Mortal Wkly Rep &#xa0;2021; 70:1235&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8437054</ArticleId><ArticleId IdType="pubmed">34499626</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwendinger &#xa0;F, Knaier &#xa0;R, Radtke &#xa0;T, Schmidt-Trucks&#xe4;ss &#xa0;A. Low cardiorespiratory fitness post-COVID-19: a narrative review. Sports Med &#xa0;2023; 53:51&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9483283</ArticleId><ArticleId IdType="pubmed">36115933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladlow &#xa0;P, O'Sullivan &#xa0;O, et al. &#xa0;The effect of medium-term recovery status after COVID-19 illness on cardiopulmonary exercise capacity in a physically active adult population. J Appl Physiol &#xa0;2022; 132:1525&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9190734</ArticleId><ArticleId IdType="pubmed">35608204</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>